Manufacturer
Modavar Pharmaceuticals
- Products listed
- 48
- Molecules
- 17
- Therapy areas
- 8
Modavar Pharmaceuticals is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 48 of its products across 17 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Indian manufacturer
- No
- Also listed as
- Modavar Pharmaceuticals LLC
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Modavar Pharmaceuticals products through licensed channels, with the documents your regulator needs.
Psychiatry
21 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Bupropion 100 mg tabletOralGeneric name | Bupropion | US FDA | Available on request |
| Bupropion 75 mg tabletOralGeneric name | Bupropion | US FDA | Available on request |
| Fluoxetine 10 mg capsuleOralGeneric name | Fluoxetine | US FDA | Available on request |
| Fluoxetine 20 mg capsuleOralGeneric name | Fluoxetine | US FDA | Available on request |
| Fluoxetine 40 mg capsuleOralGeneric name | Fluoxetine | US FDA | Available on request |
| Olanzapine 10 mg tabletOralGeneric name | Olanzapine | US FDA | Available on request |
| Olanzapine 15 mg tabletOralGeneric name | Olanzapine | US FDA | Available on request |
| Olanzapine 2.5 mg tabletOralGeneric name | Olanzapine | US FDA | Available on request |
| Olanzapine 20 mg tabletOralGeneric name | Olanzapine | US FDA | Available on request |
| Olanzapine 5 mg tabletOralGeneric name | Olanzapine | US FDA | Available on request |
| Olanzapine 7.5 mg tabletOralGeneric name | Olanzapine | US FDA | Available on request |
| Paroxetine 12.5 mg extended-release tabletOralGeneric name | Paroxetine | US FDA | Available on request |
| Paroxetine 25 mg extended-release tabletOralGeneric name | Paroxetine | US FDA | Available on request |
| Paroxetine 37.5 mg extended-release tabletOralGeneric name | Paroxetine | US FDA | Available on request |
| Rivastigmine 1.5 mg capsuleOralGeneric name | Rivastigmine | US FDA | Available on request |
| Rivastigmine 3 mg capsuleOralGeneric name | Rivastigmine | US FDA | Available on request |
| Rivastigmine 4.5 mg capsuleOralGeneric name | Rivastigmine | US FDA | Available on request |
| Rivastigmine 6 mg capsuleOralGeneric name | Rivastigmine | US FDA | Available on request |
| Venlafaxine 150 mg tabletOralGeneric name | Venlafaxine | US FDA | Available on request |
| Venlafaxine 225 mg tabletOralGeneric name | Venlafaxine | US FDA | Available on request |
| Venlafaxine 75 mg tabletOralGeneric name | Venlafaxine | US FDA | Available on request |
Cardiology
7 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Hydralazine 100 mg tabletOralGeneric name | Hydralazine | US FDA | Available on request |
| Hydralazine 25 mg tabletOralGeneric name | Hydralazine | US FDA | Available on request |
| Hydralazine 50 mg tabletOralGeneric name | Hydralazine | US FDA | Available on request |
| Nebivolol 10 mg tabletOralGeneric name | Nebivolol | US FDA | Available on request |
| Nebivolol 2.5 mg tabletOralGeneric name | Nebivolol | US FDA | Available on request |
| Nebivolol 20 mg tabletOralGeneric name | Nebivolol | US FDA | Available on request |
| Nebivolol 5 mg tabletOralGeneric name | Nebivolol | US FDA | Available on request |
Antibiotics
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Erythromycin 250 mg tabletOralGeneric name | Erythromycin | US FDA | Available on request |
| Erythromycin 500 mg tabletOralGeneric name | Erythromycin | US FDA | Available on request |
| Ofloxacin 200 mg tabletOralGeneric name | Ofloxacin | US FDA | Available on request |
| Ofloxacin 300 mg tabletOralGeneric name | Ofloxacin | US FDA | Available on request |
| Ofloxacin 400 mg tabletOralGeneric name | Ofloxacin | US FDA | Available on request |
Diabetes
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Glyburide 1.25 mg tabletOralGeneric name | Glyburide | US FDA | Available on request |
| Glyburide 2.5 mg tabletOralGeneric name | Glyburide | US FDA | Available on request |
| Glyburide 5 mg tabletOralGeneric name | Glyburide | US FDA | Available on request |
| Nateglinide 120 mg tabletOralGeneric name | Nateglinide | US FDA | Available on request |
| Nateglinide 60 mg tabletOralGeneric name | Nateglinide | US FDA | Available on request |
Ophthalmology
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Acyclovir 200 mg capsuleOralGeneric name | Acyclovir | US FDA | Available on request |
| Acyclovir 400 mg tabletOralGeneric name | Acyclovir | US FDA | Available on request |
| Acyclovir 800 mg tabletOralGeneric name | Acyclovir | US FDA | Available on request |
Oncology
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Celecoxib 400 mg capsuleOralGeneric name | Celecoxib | US FDA | Available on request |
| Celecoxib 50 mg capsuleOralGeneric name | Celecoxib | US FDA | Available on request |
Haematology
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Folic acid 1 mg tabletOralGeneric name | Folic acid | US FDA | Available on request |
Fertility
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Raloxifene 60 mg tabletOralGeneric name | Raloxifene | US FDA | Available on request |
Other products
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Tizanidine 2 mg capsuleOralGeneric name | Tizanidine | US FDA | Available on request |
| Tizanidine 4 mg capsuleOralGeneric name | Tizanidine | US FDA | Available on request |
| Tizanidine 6 mg capsuleOralGeneric name | Tizanidine | US FDA | Available on request |
Molecules made
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Modavar Pharmaceuticals
Send a request for any of these products. We confirm the licensed source, documents and lead time.